Page last updated: 2024-11-02

pd 98059 and Nociceptive Pain

pd 98059 has been researched along with Nociceptive Pain in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Nociceptive Pain: Dull or sharp aching pain caused by stimulated NOCICEPTORS due to tissue injury, inflammation or diseases. It can be divided into somatic or tissue pain and VISCERAL PAIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavao-de-Souza, GF1
Zarpelon, AC1
Tedeschi, GC1
Mizokami, SS1
Sanson, JS1
Cunha, TM1
Ferreira, SH1
Cunha, FQ1
Casagrande, R1
Verri, WA1

Other Studies

1 other study available for pd 98059 and Nociceptive Pain

ArticleYear
Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice.
    Pharmacology, biochemistry, and behavior, 2012, Volume: 101, Issue:3

    Topics: Acetic Acid; Androstadienes; Animals; Anthracenes; Benzoquinones; Disease Models, Animal; Flavonoids

2012